Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D. — Neutral

VRCA   GlobeNewsWire — March 26, 2025

WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the appointment of Noah L. Rosenberg, M.D., as Chief Medical Officer.

image for news Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D.

Trident's strategic collaboration with e-commerce players Silkoo and Haitu will combine their unique strengths to drive innovation and mutual growth Trident's strategic collaboration with e-commerce players Silkoo and Haitu will combine their unique strengths to drive innovation and mutual growth

image for news Trident Announces Strategic Collaboration with Two Global E-Commerce Firms

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Bancorp, Inc. ("Bancorp" or "the Company") (NASDAQ:TBBK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Bancorp securities between January 25, 2024 and March 4, 2025, both dates inclusive (the "Class Period").

image for news TBBK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that The Bancorp, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

SINGAPORE, March 26, 2025 (GLOBE NEWSWIRE) -- Intchains Group Limited (Nasdaq: ICG) (“we,” “us” or the “Company”), a company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies, and the active development of innovative Web3 applications, today announced it has entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Institutional Investor”) for a registered direct offering of 361,011 of its American Depositary Shares (“ADSs”), each ADS representing two Class A ordinary shares of the Company (the “Class A Ordinary Shares”) at US$2.77 per ADS. The Company has …

image for news Intchains Group Limited Announces Entry into Agreement for Registered Direct Offering of its ADSs and Warrants

SOMERSET, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of healthcare technology and AI-powered revenue cycle management (RCM) solutions, today announced the expanded adoption of its services by Alpine Ear, Nose & Throat PC, a premier otolaryngology group based in Colorado.

image for news Alpine ENT Expands Partnership with CareCloud, Implements FrontDesk Assist to Enhance Patient Experience

ADOPT Study Findings Highlight Nanox.AI's Role in Enhancing Fracture Detection and Healthcare Cost Savings

image for news Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe

MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is being studied in multiple Phase 2b clinical trials with read-outs beginning mid-2025

image for news Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress

NEW YORK CITY, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TFI International Inc. ("TFI" or "the Company") (NYSE:TFII) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TFI securities between April 26, 2024 and February 19, 2025, both dates inclusive (the "Class Period").

image for news TFII INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TFI International Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Geron Corporation ("Geron" or "the Company") (NASDAQ:GERN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Geron securities between February 28, 2024, and February 25, 2025, both dates inclusive (the "Class Period").

image for news GERN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Geron Corporation Stockholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fluence Energy, Inc. ("Fluence" or "the Company") (NASDAQ:FLNC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Fluence securities between November 29, 2023 and February 10, 2025, both dates inclusive (the "Class Period").

image for news FLNC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Fluence Energy, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ready Capital Corporation ("Ready Capital" or "the Company") (NYSE:RC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ready Capital securities between November 7, 2024 and March 2, 2025, both dates inclusive (the "Class Period").

image for news RC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ready Capital Corporation Investors Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against enCore Energy Corp. ("enCore" or "the Company") (NASDAQ:EU) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired enCore securities between March 28, 2024 and March 2, 2025, both dates inclusive (the "Class Period").

image for news EU SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that enCore Energy Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ultra Clean Holdings, Inc. ("Ultra Clean" or "the Company") (NASDAQ:UCTT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ultra Clean securities between May 6, 2024 and February 24, 2025, both dates inclusive (the "Class Period").

image for news UCTT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultra Clean Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or "the Company") (NASDAQ:SANA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Sana securities between March 17, 2023 and November 4, 2024, both dates inclusive (the "Class Period").

image for news SANA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Perpetua Resources Corp. ("Perpetua" or "the Company") (NASDAQ: PPTA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Perpetua securities between April 17, 2024 and February 13, 2025, both dates inclusive (the "Class Period").

image for news PPTA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Perpetua Resources Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zynex securities between March 13, 2023 and March 11, 2025, both dates inclusive (the "Class Period").

image for news ZYXI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zynex, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

HOLON, Israel , March 26, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that management will participate in the following upcoming virtual investor conferences in April 2025: H.C.

image for news Compugen to Participate in Multiple Virtual Investor Conferences in April 2025

LONDON--(BUSINESS WIRE)--BWT Alpine Formula One Team and luxury skiwear and lifestyle brand Perfect Moment Ltd. [NYSE American: PMNT] will come together to reveal a special-edition, capsule collection that effortlessly fuses Perfect Moment's refined ski lifestyle with the team's cutting-edge, racing performance. The sophisticated collection brings together two brands born in the French Alps with BWT Alpine Formula One Team's motor racing heritage and Perfect Moment, founded in the mountains nea.

image for news BWT Alpine Formula One Team and Perfect Moment to Launch Capsule Skiwear Collection

Updated data confirms statistically significant 32% higher ORR and 3.5 month longer PFS in second-line CRC patients with high DKK1 levels treated with sirexatamab plus bevacizumab and chemotherapy Statistically significant 22% higher ORR and 2.6 month longer PFS in patients who had not had prior anti-VEGF therapy Leap to host a conference call to present clinical data today, March 26, 2025, at 8:00 a.m. ET CAMBRIDGE, Mass.

image for news Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study

Lightspeed projects for the next three years: Gross profit CAGR of ~20-25%1 and Customer Location2 CAGR of ~10-15% 1 in its two growth engines - retail in North America and hospitality in Europe Consolidated gross profit CAGR of ~15-18%1 Adjusted EBITDA to grow to ~20% of gross profit in Fiscal 20281,5 Free Cash Flow5 of ~$100 million in Fiscal 20281 Lightspeed also completed Fiscal 2025 share repurchases of over $130 million 3 Additional share repurchase of up to ~$300 million authorized for a total of $430 million Lightspeed reports in US dollars and in accordance with IFRS. MONTREAL , March …

image for news Lightspeed to Outline Three Year Strategy at 2025 Capital Markets Day